Mirabella Financial Services LLP Buys 2,734,728 Shares of The Beauty Health Company $SKIN

Mirabella Financial Services LLP grew its stake in The Beauty Health Company (NASDAQ:SKIN) by 21.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,596,277 shares of the company’s stock after purchasing an additional 2,734,728 shares during the period. Beauty Health makes up about 2.6% of Mirabella Financial Services LLP’s holdings, making the stock its 6th largest holding. Mirabella Financial Services LLP owned approximately 12.23% of Beauty Health worth $31,037,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Woodline Partners LP boosted its holdings in Beauty Health by 255.9% during the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after acquiring an additional 4,263,997 shares during the period. Soleus Capital Management L.P. acquired a new position in Beauty Health in the second quarter valued at approximately $1,910,000. Geode Capital Management LLC grew its position in shares of Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock valued at $4,399,000 after buying an additional 496,963 shares during the last quarter. Bank of America Corp DE lifted its holdings in shares of Beauty Health by 482.3% in the 3rd quarter. Bank of America Corp DE now owns 336,382 shares of the company’s stock valued at $669,000 after purchasing an additional 278,616 shares during the last quarter. Finally, Squarepoint Ops LLC acquired a new stake in shares of Beauty Health in the third quarter valued at approximately $448,000. Institutional investors and hedge funds own 93.26% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on SKIN shares. TD Cowen reduced their price target on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research report on Monday. Zacks Research raised shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday. Benchmark restated a “hold” rating on shares of Beauty Health in a research report on Friday, March 13th. Canaccord Genuity Group reiterated a “hold” rating and issued a $1.50 price target on shares of Beauty Health in a report on Friday, March 13th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a report on Wednesday, January 14th. One equities research analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $2.42.

Beauty Health Stock Performance

Shares of SKIN opened at $1.18 on Thursday. The company has a market capitalization of $150.45 million, a price-to-earnings ratio of -5.90 and a beta of 1.20. The company’s 50 day simple moving average is $1.25 and its 200 day simple moving average is $1.50. The Beauty Health Company has a 1 year low of $0.78 and a 1 year high of $2.69. The company has a debt-to-equity ratio of 3.94, a quick ratio of 1.40 and a current ratio of 1.66.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, March 12th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Beauty Health had a negative return on equity of 15.40% and a negative net margin of 3.16%.The firm had revenue of $82.37 million for the quarter, compared to the consensus estimate of $78.07 million. On average, sell-side analysts predict that The Beauty Health Company will post -0.25 EPS for the current year.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.